Martin Bhatt

Martin Bhatt is a specialist in adrenocortical carcinoma (ACC), a rare aggressive malignancy arising from the adrenal cortex. His research investigates the molecular pathogenesis of ACC, including mutations in Wnt signaling and steroidogenic pathways. He has contributed to clinical trials of mitotane and platinum-based chemotherapy and is investigating targeted therapies and immunotherapy for ACC. His translational work aims to identify actionable vulnerabilities in adrenal tumors through comprehensive genomic profiling.